Viridian Therapeutics, Inc. · NASDAQ:VRDN

Commodore Capital LP reported a 5.30% stake in Viridian Therapeutics, Inc. (Schedule 13G)

Event Apr 4, 2025 · Filed Apr 11, 2025

Commodore Capital LP reported a 5.30% stake in Viridian Therapeutics, Inc., 4,300,000 shares, as a passive investor on Apr 4, 2025. Filed Apr 11, 2025 (Schedule 13G).

Stake
5.30%
Shares
4,300,000
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Commodore Capital LP5.30%4,300,000
Commodore Capital Master LP5.30%4,300,000

Source

View original at SEC

Related